CGH
NEO icon

Crossmark Global Holdings’s NeoGenomics NEO Stock Holding History

Crossmark Global Holdings’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,494
Closed -$409K – 1326
2024
Q2 		$409K Buy
29,494
+842
+3% +$11.9K 0.01% 913
2024
Q1 		$450K Buy
28,652
+6,394
+29% +$98.7K 0.01% 917
2023
Q4 		$360K Sell
22,258
-103
-0.5% -$1.69K 0.01% 980
2023
Q3 		$285K Buy
22,361
+645
+3% +$9.59K 0.01% 1036
2023
Q2 		$375K Sell
21,716
-374
-2% -$6.16K 0.01% 966
2023
Q1 		$384K Buy
22,090
+1,304
+6% +$18.6K 0.01% 935
2022
Q4 		$192K Sell
20,786
-177
-0.8% -$1.65K ﹤0.01% 1205
2022
Q3 		$181K Buy
20,963
+130
+0.6% +$1.29K 0.01% 1185
2022
Q2 		$170K Hold
20,833
– – ﹤0.01% 1230
2022
Q1 		$254K Buy
20,833
+1,450
+7% +$30.5K 0.01% 1208
2021
Q4 		$661K Buy
19,383
+2,228
+13% +$87.3K 0.01% 787
2021
Q3 		$828K Sell
17,155
-445
-3% -$20.6K 0.02% 672
2021
Q2 		$795K Sell
17,600
-90
-0.5% -$3.99K 0.02% 688
2021
Q1 		$853K Sell
17,690
-90
-0.5% -$4.69K 0.02% 651
2020
Q4 		$957K Buy
17,780
+1,470
+9% +$66.4K 0.02% 585
2020
Q3 		$602K Buy
16,310
+100
+0.6% +$3.72K 0.02% 695
2020
Q2 		$502K Buy
16,210
+130
+0.8% +$3.6K 0.01% 751
2020
Q1 		$444K Sell
16,080
-200
-1% -$5.99K 0.02% 693
2019
Q4 		$476K Sell
16,280
-13,490
-45% -$321K 0.01% 828
2019
Q3 		$569K Buy
29,770
+120
+0.4% +$2.81K 0.02% 735
2019
Q2 		$651K Sell
29,650
-1,190
-4% -$26.1K 0.02% 693
2019
Q1 		$631K Buy
+30,840
New +$536K 0.02% 708

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Crossmark Global Holdings's NEO Position: Q3 2024 in Review

Crossmark Global Holdings sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 29,494 shares — an estimated $409K sold.

Crossmark Global Holdings first reported a position in NEO in Q1 2019 and held it in 22 quarters. The position peaked at $957K in Q4 2020. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Crossmark Global Holdings reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 29,494 NeoGenomics shares in Q3 2024, an estimated $409K.
  • Crossmark Global Holdings first reported a position in NeoGenomics in Q1 2019 and held it in 22 quarters.
  • Crossmark Global Holdings's NeoGenomics position peaked at $957K in Q4 2020.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Crossmark Global Holdings's 13F filing for Q3 2024, filed 4 Nov 2024.